Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Dec 21, 2016
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2016-12-19$1.96/sh−800$1,568→ 0 total
4 · Orexigen Therapeutics, Inc. · Filed Dec 21, 2016
Common Stock